Masetti, R.; Bossu, G.; Muratore, E.; Leardini, D.; Gatti, M.; Di Sario, R.; Pea, F.; Esposito, S., Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine, «PAEDIATRIC DRUGS», 2024, 27, pp. 41 - 56 [articolo]
Gatti, Milo; Viale, Pierluigi; Pea, Federico, Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 79, pp. 195 - 199 [articolo]
Gatti, Milo; Viale, Pierluigi; Cojutti, Pier Giorgio; Zamparini, Eleonora; De Paolis, Massimiliano; Giannella, Maddalena; Pea, Federico; Tedeschi, Sara, A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, Article number: 106773, pp. 1 - 8 [articolo]Open Access
Gatti M.; Rinaldi M.; Gaibani P.; Siniscalchi A.; Tonetti T.; Giannella M.; Viale P.; Pea F., A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam for treating DTR gram-negative infections in a case series of critically ill patients undergoing continuous veno-venous haemodiafiltration (CVVHDF), «JOURNAL OF CRITICAL CARE», 2023, 76, Article number: 154301, pp. 1 - 6 [articolo]Open Access
Gatti, Milo; Pascale, Renato; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Conti, Matteo; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of critically ill renal patients treated for documented carbapenem-resistant Gram-negative bloodstream infections and/or ventilator-associated pneumonia, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, pp. 1 - 7 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Gaibani, Paolo; Siniscalchi, Antonio; Tonetti, Tommaso; Viale, Pierluigi; Pea, Federico, A descriptive pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 62, Article number: 106992, pp. 1 - 3 [articolo]
Gatti, Milo; Tam, Vincent H; Gaibani, Paolo; Cojutti, Pier Giorgio; Viale, Pierluigi; Pea, Federico, A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2023, 61, Article number: 106760, pp. 1 - 3 [articolo]Open Access
Cojutti, Pier Giorgio; Pea, Federico, Azacitidine for Acute Myeloid Leukemia: Why One Dose Does Not Fit All, «CLINICAL PHARMACOLOGY & THERAPEUTICS», 2023, 10.1002/cpt.3154, pp. 1 - 1 [replica/breve intervento]
Gatti, Milo; Fornaro, Giacomo; Viale, Pierluigi; Pea, Federico; Giannella, Maddalena, Clinical efficacy of renal dosing adjustments of ceftazidime‐avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: a systematic review and meta‐analysis of observational studies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2023, 89, pp. 617 - 629 [articolo]
Gaibani, Paolo; Bovo, Federica; Bussini, Linda; Bartoletti, Michele; Lazzarotto, Tiziana; Viale, Pierluigi; Pea, Federico; Ambretti, Simone, Colonization by ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae following therapy in critically ill patients, «CLINICAL MICROBIOLOGY AND INFECTION», 2023, 29, pp. 654.e1 - 654.e4 [articolo]
Gatti, Milo; Pea, Federico, Comment on: pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2023, 78, pp. 1556 - 1557 [replica/breve intervento]
Gatti, Milo; Rinaldi, Matteo; Bonazzetti, Cecilia; Gaibani, Paolo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2023, 67, Article number: e0096923, pp. 1 - 12 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia?, «ANTIBIOTICS», 2023, 12, Article number: 1736, pp. 1 - 10 [articolo]Open Access
Liu, Chun; Cojutti, Pier Giorgio; Giannella, Maddalena; Roberto, Marcello; Casadei, Beatrice; Cristiano, Gianluca; Papayannidis, Cristina; Vianelli, Nicola; Zinzani, Pier Luigi; Viale, Pierluigi; Bonifazi, Francesca; Pea, Federico, Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study, «PHARMACEUTICS», 2023, 15, Article number: 1022, pp. 1 - 13 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Potena, Luciano; Salvaterra, Elena; Morelli, Maria Cristina; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?, «TRANSPLANT INFECTIOUS DISEASE», 2023, -, Article number: e14107, pp. 1 - 8 [articolo]Open Access
